左心室辅助器械 (LVAD) 患者抗凝模式的发展:专注于直接口服抗凝剂
Andrew Ndakotsu1, Adhvithi Pingili2, Lida Koskina2
1Department of Medicine, MedStar Health Georgetown University, Baltimore, MD, USA. Andrew.k.Ndakotsu@medstar.net.
Heart failure reviews
|June 17, 2025
概括
直接口服抗凝剂 (DOAC) 对左心室辅助器件 (LVAD) 患者有希望,可能比华法林提供更好的安全性和坚持性. 需要进一步的研究,特别是对HeartMate 3 (HM3) 设备用户进行进一步的研究,以确认最佳的抗凝策略.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
背景情况:
- 对左心室辅助器械 (LVAD) 患者来说,抗凝药非常重要,以防止凝块和出血.
- 华法林是标准的,但有局限性;直接口服抗凝剂 (DOAC) 是新兴的替代品.
- 先进的HeartMate 3 (HM3) LVAD可能允许更简单的抗凝血疗法.
研究的目的:
- 审查目前关于对LVAD患者的DOACs的证据.
- 为了将DOAC与华法林进行比较,考虑不同的LVAD设备类型.
- 确定对LVAD支持的抗凝固管理未来研究的需要.
主要方法:
- 对回顾性研究和临床数据的文献综述.
- 分析使用DOAC与华法林的抗凝结结果 (血栓栓塞,出血).
- 在现代 (HM3) 和传统LVAD中对DOAC的评估.
主要成果:
- 追溯数据表明,像阿皮克萨班这样的DOAC可能具有与华法林相似的疗效,并可能降低出血风险,特别是在没有阿司匹林的情况下.
- 由于可预测的药理动力学和较少的监测,DOACs提供了更简单的管理.
- 证据受到小型研究和包含具有不同风险的旧LVADs的限制.
结论:
- 对LVAD患者来说,DOACs代表了华法林的有希望的替代品.
- 更大规模的前性试验是必不可少的,特别是对于HeartMate 3设备接收者.
- 确定现代LVAD的最佳抗凝策略需要进一步研究.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Anticoagulant Drugs: Low-Molecular-Weight Heparins
932
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
932
Cardiomyopathy V: Interprofessional Care
41
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
656
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
656
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
48
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
48


